Description: At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Home Page: www.travere.com
TVTX Technical Analysis
3611 Valley Centre Drive
San Diego,
CA
92130
United States
Phone:
888 969 7879
Officers
| Name | Title |
|---|---|
| Dr. Eric M. Dube Ph.D. | Pres, CEO & Director |
| Ms. Elizabeth E. Reed | Sr. VP, Gen. Counsel & Corp. Sec. |
| Dr. William E. Rote Ph.D. | Sr. VP of R&D |
| Dr. Noah L. Rosenberg M.D. | Exec. Advisor |
| Mr. Christopher Cline C.F.A., CFA | Chief Financial Officer |
| Ms. Sandra Calvin | VP, Corp. Controller & Principal Accounting Officer |
| Ms. Charlotte Smith | Sr. VP of Public Affairs |
| Mr. Casey Logan | Sr. VP of Corp. & Bus. Devel. |
| Ms. Angela Giannantonio | Sr. VP of HR |
| Mr. Peter Heerma | Chief Commercial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 11.939 |
| Price-to-Sales TTM: | 5.5633 |
| IPO Date: | 2012-11-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 310 |